Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

No trades
See on Supercharts

SGMO fundamentals

The current financial position of Sangamo Therapeutics, Inc.

Total assets of SGMO for Q2 24 is 93.01 M USD, 27.87% less than the previous Q1 24. And total liabilities decreased by 4.07% in Q2 24 to 69.32 M USD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total assets
Total liabilities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Total assetsYoY growth
Total equityYoY growth